The management of metastatic prostate cancer has undergone a radical shift from sequential hormone therapy to...

Beyond the standard “triplet therapy” and established hormone treatments, the research landscape for 2026 is...

The clinical landscape of prostate cancer management in 2026 is marked by a sweeping integration of diagnostic precision...